These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30950979)

  • 21. Cardiac sympathetic activation in patients with pulmonary arterial hypertension.
    Mak S; Witte KK; Al-Hesayen A; Granton JJ; Parker JD
    Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(10):R1153-7. PubMed ID: 22422664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure.
    Notarius CF; Butler GC; Ando S; Pollard MJ; Senn BL; Floras JS
    Clin Sci (Lond); 1999 Jun; 96(6):557-65. PubMed ID: 10334961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
    Kasama S; Toyama T; Sumino H; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
    Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
    Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of lipophilic and hydrophilic statins on muscle sympathetic nerve activity in heart failure with preserved left ventricular ejection fraction.
    Tokuhisa H; Murai H; Okabe Y; Hamaoka T; Sugimoto H; Mukai Y; Inoue O; Takashima SI; Kato T; Usui S; Furusho H; Kaneko S; Takamura M
    Auton Neurosci; 2018 Sep; 213():8-14. PubMed ID: 30005743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
    Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
    J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
    Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
    J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.
    Newton GE; Tong JH; Schofield AM; Baines AD; Floras JS; Parker JD
    J Am Coll Cardiol; 1996 Jul; 28(1):155-61. PubMed ID: 8752808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure.
    Azevedo ER; Newton GE; Floras JS; Parker JD
    Circulation; 2000 May; 101(17):2053-9. PubMed ID: 10790346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity.
    Mansfield D; Kaye DM; Brunner La Rocca H; Solin P; Esler MD; Naughton MT
    Circulation; 2003 Mar; 107(10):1396-400. PubMed ID: 12642360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart Failure-Specific Relationship Between Muscle Sympathetic Nerve Activity and Aortic Wave Reflection.
    Millar PJ; Notarius CF; Haruki N; Floras JS
    J Card Fail; 2019 May; 25(5):404-408. PubMed ID: 30862489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Hisanaga T; Wada A; Maeda K; Ohnishi M; Fukai D; Mabuchi N; Sawaki M; Kinoshita M
    J Am Coll Cardiol; 1998 Feb; 31(2):391-8. PubMed ID: 9462584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis.
    Quarti-Trevano F; Biffi A; Bonzani M; Seravalle G; Corrao G; Mancia G; Grassi G
    J Hypertens; 2021 Nov; 39(11):2281-2289. PubMed ID: 34620811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electroacupuncture improves cardiac function and remodeling by inhibition of sympathoexcitation in chronic heart failure rats.
    Ma L; Cui B; Shao Y; Ni B; Zhang W; Luo Y; Zhang S
    Am J Physiol Heart Circ Physiol; 2014 May; 306(10):H1464-71. PubMed ID: 24585780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated Sympathetic Blood Pressure Transduction in Patients With Treated Heart Failure With Reduced Ejection Fraction.
    Nardone M; Notarius CF; Badrov MB; Millar PJ; Floras JS
    Hypertension; 2022 Dec; 79(12):2764-2773. PubMed ID: 36252088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Arenare F; Spaziani D; Mancia G
    Hypertension; 2009 Feb; 53(2):205-9. PubMed ID: 19124679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.
    Machackova J; Sanganalmath SK; Barta J; Dhalla KS; Dhalla NS
    Cardiovasc Toxicol; 2010 Mar; 10(1):9-16. PubMed ID: 19949891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies.
    Quarti Trevano F; Dell'Oro R; Biffi A; Seravalle G; Corrao G; Mancia G; Grassi G
    J Hypertens; 2020 Apr; 38(4):565-572. PubMed ID: 32132429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal and excessive muscle sympathetic nerve activity in heart failure: implications for future trials of therapeutic autonomic modulation.
    Badrov MB; Keir DA; Tomlinson G; Notarius CF; Millar PJ; Kimmerly DS; Shoemaker JK; Keys E; Floras JS
    Eur J Heart Fail; 2023 Feb; 25(2):201-210. PubMed ID: 36459000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias.
    Grassi G; Seravalle G; Dell'Oro R; Facchini A; Ilardo V; Mancia G
    J Hypertens; 2004 Sep; 22(9):1747-53. PubMed ID: 15311103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.